462 related articles for article (PubMed ID: 24850137)
1. Dendritic cell immunotherapy for glioblastoma.
Polyzoidis S; Ashkan K
Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial.
Cho DY; Yang WK; Lee HC; Hsu DM; Lin HL; Lin SZ; Chen CC; Harn HJ; Liu CL; Lee WY; Ho LH
World Neurosurg; 2012; 77(5-6):736-44. PubMed ID: 22120301
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.
Rapp M; Grauer OM; Kamp M; Sevens N; Zotz N; Sabel M; Sorg RV
Trials; 2018 May; 19(1):293. PubMed ID: 29801515
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell vaccines to combat glioblastoma.
Wheeler CJ
Expert Rev Neurother; 2010 Apr; 10(4):483-6. PubMed ID: 20367199
[No Abstract] [Full Text] [Related]
5. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
[TBL] [Abstract][Full Text] [Related]
6. Current status of immunotherapy and gene therapy for high-grade gliomas.
Marsh JC; Goldfarb J; Shafman TD; Diaz AZ
Cancer Control; 2013 Jan; 20(1):43-8. PubMed ID: 23302906
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy trials for glioblastoma multiforme: promise and pitfalls.
Yong RL; Lonser RR
World Neurosurg; 2012; 77(5-6):636-8. PubMed ID: 22120230
[No Abstract] [Full Text] [Related]
8. Advances in Immunotherapy for Glioblastoma Multiforme.
Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X
J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344
[TBL] [Abstract][Full Text] [Related]
9. Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients.
Nava S; Lisini D; Pogliani S; Dossena M; Bersano A; Pellegatta S; Parati E; Finocchiaro G; Frigerio S
Stem Cells Transl Med; 2015 Oct; 4(10):1164-72. PubMed ID: 26273063
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.
Wang X; Zhao HY; Zhang FC; Sun Y; Xiong ZY; Jiang XB
Cancer Invest; 2014 Nov; 32(9):451-7. PubMed ID: 25259676
[TBL] [Abstract][Full Text] [Related]
11. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
Van Gool S; De Vleeschouwer S
Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731
[No Abstract] [Full Text] [Related]
12. Vaccine-based immunotherapy for glioblastoma.
Thomas AA; Fisher JL; Ernstoff MS; Fadul CE
CNS Oncol; 2013 Jul; 2(4):331-49. PubMed ID: 25054578
[TBL] [Abstract][Full Text] [Related]
13. Hope and challenges for dendritic cell-based vaccine therapy for glioblastoma.
Nakano I; Chiocca EA
World Neurosurg; 2012; 77(5-6):633-5. PubMed ID: 22120228
[No Abstract] [Full Text] [Related]
14. Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.
Ardon H; Van Gool S; Lopes IS; Maes W; Sciot R; Wilms G; Demaerel P; Bijttebier P; Claes L; Goffin J; Van Calenbergh F; De Vleeschouwer S
J Neurooncol; 2010 Sep; 99(2):261-72. PubMed ID: 20146084
[TBL] [Abstract][Full Text] [Related]
15. DCVax®-L--developed by Northwest Biotherapeutics.
Polyzoidis S; Ashkan K
Hum Vaccin Immunother; 2014; 10(11):3139-45. PubMed ID: 25483653
[TBL] [Abstract][Full Text] [Related]
16. The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
Reardon DA; Mitchell DA
Semin Immunopathol; 2017 Feb; 39(2):225-239. PubMed ID: 28138787
[TBL] [Abstract][Full Text] [Related]
17. Agenus cancer vaccine extends survival of GBM patients.
Riedmann EM
Hum Vaccin Immunother; 2014; 10(2):252-3. PubMed ID: 24963517
[No Abstract] [Full Text] [Related]
18. Vaccine for aggressive brain tumors may prolong survival.
Health News; 2004 Dec; 10(12):7. PubMed ID: 15645564
[No Abstract] [Full Text] [Related]
19. Trials and tribulations of cancer immunotherapy: the dendritic cell vaccine shows promise in a phase I glioblastoma multiforme trial.
Gürsel DB; Schlaff CD; Boockvar JA
Neurosurgery; 2012 Dec; 71(6):N19-21. PubMed ID: 23160396
[No Abstract] [Full Text] [Related]
20. Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.
Pellegatta S; Poliani PL; Corno D; Grisoli M; Cusimano M; Ubiali F; Baggi F; Bruzzone MG; Finocchiaro G
Neurol Res; 2006 Jul; 28(5):527-31. PubMed ID: 16808884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
